Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer

Comprehensive genomic profiling for advanced non-small cell lung cancer (NSCLC) can identify patients for molecularly targeted therapies that improve clinical outcomes. We analyzed data from 3084 patients (median age 65 years, 72.9% with adenocarcinoma) with advanced NSCLC registered in a real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Steven, Liao, Jiemin, Hayashi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318660/
https://www.ncbi.nlm.nih.gov/pubmed/35877242
http://dx.doi.org/10.3390/curroncol29070382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318660/
https://www.ncbi.nlm.nih.gov/pubmed/35877242
http://dx.doi.org/10.3390/curroncol29070382

Ejemplares similares